Expiration Date: 2/1/2016
Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range of options for managing patients with obesity…go to activity»
This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.
Expiration Date: 12/15/2015
Obesity is associated with a wide range of comorbid conditions, including diabetes, hypertension, sleep apnea, and cardiovascular disease. Clinicians must consider the…go to activity»
This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.
Expiration Date: 12/1/2015
Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options include behavior modification, commercially…go to activity»